| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/29/1996 | CA2198279A1 Antigenic peptides derived from the g protein of rsv for type- and subtype-specific diagnosis of respiratory syncytial virus (rsv) infection |
| 02/29/1996 | CA2198265A1 New immunocontraceptive peptides |
| 02/29/1996 | CA2198234A1 Live vaccine for the treatment of tumour diseases |
| 02/29/1996 | CA2198219A1 Human chemokine polypeptides |
| 02/29/1996 | CA2198207A1 Cell adhesion peptides for use in modifying mutual adhesion among eukaryotic cells |
| 02/29/1996 | CA2198206A1 Human chemokine beta-9 |
| 02/29/1996 | CA2197890A1 Retinoblastoma protein-interacting zinc finger proteins |
| 02/29/1996 | CA2197864A1 Peptide libraries as a source of syngenes |
| 02/29/1996 | CA2197650A1 Method of treating birds with avian myelomonocytic growth factor |
| 02/29/1996 | CA2197562A1 Haemophilus adherence and penetration proteins |
| 02/29/1996 | CA2197242A1 Regulatable elimination of gene expression, gene product function and engineered host cells |
| 02/29/1996 | CA2196997A1 Glutamate receptor |
| 02/29/1996 | CA2196892A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 02/29/1996 | CA2196311A1 Genetically engineered swine cells |
| 02/28/1996 | EP0698667A1 Xylanase, microorganisms for its production, DNA molecules, process of preparation and use thereof |
| 02/28/1996 | EP0698666A2 Modified epimorphin |
| 02/28/1996 | EP0698665A2 Infectious Tick-Borne Encephalitis virus cDNA clone, recombinant vaccine derived therefrom and preparation thereof |
| 02/28/1996 | EP0698616A1 Process for the preparation of a C1-esterase inhibitor (C1-1NH) concentrate and therapeutical use thereof |
| 02/28/1996 | EP0698615A1 Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 02/28/1996 | EP0698614A1 Endothelin-antagonizing peptide |
| 02/28/1996 | EP0698216A1 Methods of typing hepatitis c virus and reagents for use therein |
| 02/28/1996 | EP0698214A1 Hiv immunoassay utilizing recombinant protein and synthetic peptide reagents |
| 02/28/1996 | EP0698123A1 Means for detecting familial colon cancer (fcc) |
| 02/28/1996 | EP0698121A1 Methods for nucleic acid detection, sequencing, and cloning using exonuclease |
| 02/28/1996 | EP0698116A1 Processes for producing an enzyme |
| 02/28/1996 | EP0698115A1 Methods and compositions relating to sterol regulatory element binding proteins |
| 02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
| 02/28/1996 | EP0698108A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
| 02/28/1996 | EP0698107A1 Gene therapy for haemophilia |
| 02/28/1996 | EP0698104A1 Hippuricase gene |
| 02/28/1996 | EP0698101A1 Hepatitis-c virus type 4, 5 and 6 |
| 02/28/1996 | EP0698100A1 Hybrid picornaviruses expressing chlamydial epitopes |
| 02/28/1996 | EP0698099A1 Method for the culture in vitro of differents stages of tissue parasites |
| 02/28/1996 | EP0698098A1 Method for obtaining male-sterile plants |
| 02/28/1996 | EP0698097A1 PRODUCTION OF ANTIBODIES OR (FUNCTIONALIZED) FRAGMENTS THEREOF DERIVED FROM HEAVY CHAIN IMMUNOGLOBULINS OF $i(CAMELIDAE) |
| 02/28/1996 | EP0698096A1 Expression of ntrk1-derived oncogenes in pc12 pheochromocytoma cells and use thereof for the screening of anti-tyrosine kinase compounds |
| 02/28/1996 | EP0698095A1 Bmp-10 compositions |
| 02/28/1996 | EP0698094A1 Bmp-11 compositions |
| 02/28/1996 | EP0698093A1 VON HIPPEL-LINDAU (VHL) DISEASE GENE AND CORRESPONDING cDNA AND METHODS FOR DETECTING CARRIERS OF THE VHL DISEASE GENE |
| 02/28/1996 | EP0698091A1 Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
| 02/28/1996 | EP0698089A1 Nucleic acid encoding amp-activated protein kinase |
| 02/28/1996 | EP0698086A1 Yeast strain and methods for expressing heterologous proteins in yeast |
| 02/28/1996 | EP0698040A1 Lhrh antagonists |
| 02/28/1996 | EP0698039A1 Peptides for suppression of myeloid progenitor cell proliferation and treatment of septic shock |
| 02/28/1996 | EP0698038A1 Method of separating glycosylated and non-glycosylated proteins |
| 02/28/1996 | EP0698036A1 Process for removing endotoxins |
| 02/28/1996 | EP0697906A1 Artificial receptors, antibodies, and enzymes |
| 02/28/1996 | EP0697893A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 02/28/1996 | EP0697891A1 Polyoxime compounds and their preparation |
| 02/28/1996 | EP0697888A1 Conserved motif of hepatitis c virus e2/ns1 region |
| 02/28/1996 | EP0697883A1 Use of platelet-derived growth factor to improve collateral circulation |
| 02/28/1996 | EP0697880A1 Inhibition of leukocyte adhesion |
| 02/28/1996 | EP0697857A1 Hookworm anticoagulant |
| 02/28/1996 | EP0511967B1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies |
| 02/28/1996 | EP0428629B1 Synthetic polypeptides and antibodies related to epstein-barr virus nuclear antigen |
| 02/28/1996 | EP0362367B1 Osteogenic devices |
| 02/28/1996 | CN1117526A Recombinant single chain Fv antibody fragment and its use in the immunopurification of the recombinant hepatitus B virus surface antigen |
| 02/27/1996 | US5495071 Genetic engineering |
| 02/27/1996 | US5495070 Genetically engineering cotton plants for altered fiber |
| 02/27/1996 | US5495007 Phloem-specific promoter |
| 02/27/1996 | US5495001 Recombinant purified protease nexin |
| 02/27/1996 | US5495000 Anticoagulant peptides |
| 02/27/1996 | US5494999 For assaying, purifying or inducing cdw52 antibody |
| 02/27/1996 | US5494897 Pentapeptides, linear or cyclic |
| 02/27/1996 | US5494896 Administering bactericidal permeability-increasing protein |
| 02/27/1996 | US5494895 Scorpion peptide margatoxin with immunosuppressant activity |
| 02/27/1996 | US5494894 Using a pentapeptide |
| 02/27/1996 | US5494818 A fusion protein encoded by the dna which specifically cleaves in vitro between c-terminal residue of ubiquitin and n-terminal residue of protein |
| 02/27/1996 | US5494815 Polymer crosslinked by radiation or peroxide to form epoxide groups which react with substance to be immobilized; remaining epoxy groups stabilized with amine, carboxy or aminoacid components |
| 02/27/1996 | US5494813 Nematode control with proteinase inhibitors |
| 02/27/1996 | US5494808 Defined medium OMPC fermentation process |
| 02/27/1996 | US5494807 NYVAC vaccinia virus recombinants comprising heterologous inserts |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
| 02/27/1996 | US5494802 Tissue antigen and diagnostic method for human osteoporosis using the same |
| 02/27/1996 | US5494792 Kainate-binding, human CNS receptors of the EAA2 family |
| 02/27/1996 | US5494672 Pseudomonas peptide composition and method |
| 02/27/1996 | US5494671 Vaccine |
| 02/27/1996 | US5494663 Treatment of microbial infection with interleukin 1 polypeptides |
| 02/26/1996 | CA2156767A1 Binding agent for growth factor |
| 02/25/1996 | CA2692337A1 Purification of alpha-1 proteinase inhibitor using novel chromatographic separation conditions |
| 02/24/1996 | WO1996006181A1 Method of modifying protein |
| 02/22/1996 | WO1996005325A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996005324A1 Method for in vitro detection of a predisposition to myocardial infarction and diagnostic kit |
| 02/22/1996 | WO1996005322A1 Detection and treatment of breast cancer |
| 02/22/1996 | WO1996005315A2 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 02/22/1996 | WO1996005314A2 Protein toxins active against lepidopteran pests |
| 02/22/1996 | WO1996005313A1 VACCINES CONTAINING BORRELIA BURGDORFERI OspG |
| 02/22/1996 | WO1996005312A1 Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease |
| 02/22/1996 | WO1996005311A1 Biologically active porcine somatotropin polypeptide and methods of using the same |
| 02/22/1996 | WO1996005310A1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 02/22/1996 | WO1996005309A2 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
| 02/22/1996 | WO1996005308A1 Method for diagnosing a predisposition for breast and ovarian cancer |
| 02/22/1996 | WO1996005307A2 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
| 02/22/1996 | WO1996005306A2 IN VIVO MUTATIONS AND POLYMORPHISMS IN THE 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE |
| 02/22/1996 | WO1996005305A1 Use of zrk peptide sequences in contraception |
| 02/22/1996 | WO1996005304A1 Integrin blocking molecules |
| 02/22/1996 | WO1996005303A1 Cloning and regulation of an endothelial cell protein c/activated protein c receptor |
| 02/22/1996 | WO1996005302A1 G protein coupled receptor protein, production, and use thereof |
| 02/22/1996 | WO1996005301A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | WO1996005300A2 Or-1 on orphan receptor belonging to the nuclear receptor family |